Company Nuo Therapeutics, Inc. Other OTC
Equities
AURX
US67059V2097
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Innovative Cell-based Technologies
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +442.12% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +442.12% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Jorden
CEO | Chief Executive Officer | 61 | 19/08/19 |
Peter Clausen
COO | Chief Operating Officer | 58 | 01/08/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
C. Eric Winzer
BRD | Director/Board Member | 67 | 30/09/30 |
David Jorden
CEO | Chief Executive Officer | 61 | 19/08/19 |
Paul D. Mintz
BRD | Director/Board Member | 75 | 07/17/07 |
Scott Pittman
BRD | Director/Board Member | 65 | 05/16/05 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 44,241,516 | 17,391,995 ( 39.31 %) | 0 | 39.31 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+10.44% | 107B | |
+0.82% | 106B | |
+6.72% | 23.47B | |
-13.89% | 21.9B | |
-6.64% | 18.77B | |
-37.26% | 17.85B | |
-10.98% | 16.78B | |
+8.67% | 14.41B | |
+41.08% | 12.86B |